NO974566L - Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse - Google Patents

Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse

Info

Publication number
NO974566L
NO974566L NO974566A NO974566A NO974566L NO 974566 L NO974566 L NO 974566L NO 974566 A NO974566 A NO 974566A NO 974566 A NO974566 A NO 974566A NO 974566 L NO974566 L NO 974566L
Authority
NO
Norway
Prior art keywords
amino acid
side chain
independently represents
autoimmune diseases
acid residue
Prior art date
Application number
NO974566A
Other languages
English (en)
Norwegian (no)
Other versions
NO974566D0 (no
Inventor
Nobuyuki Yamagata
Kenji Ogata
Masako Wagatsuma
Hitoshi Takanashi
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO974566D0 publication Critical patent/NO974566D0/no
Publication of NO974566L publication Critical patent/NO974566L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO974566A 1995-04-07 1997-10-02 Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse NO974566L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11759295 1995-04-07
JP7344649A JPH08333390A (ja) 1995-04-07 1995-11-24 ペプチド及びそれからなる自己免疫疾患治療剤
PCT/JP1996/000917 WO1996031529A1 (fr) 1995-04-07 1996-04-03 Peptides et medicaments contre les maladies auto-immunes contenant ces peptides

Publications (2)

Publication Number Publication Date
NO974566D0 NO974566D0 (no) 1997-10-02
NO974566L true NO974566L (no) 1997-11-26

Family

ID=26455689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974566A NO974566L (no) 1995-04-07 1997-10-02 Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse

Country Status (13)

Country Link
EP (1) EP0821003B1 (es)
JP (1) JPH08333390A (es)
KR (1) KR19980703610A (es)
CN (1) CN1183784A (es)
AT (1) ATE247664T1 (es)
AU (1) AU704656B2 (es)
CA (1) CA2217679C (es)
DE (1) DE69629559T2 (es)
ES (1) ES2203685T3 (es)
HU (1) HUP9801680A3 (es)
NO (1) NO974566L (es)
NZ (1) NZ304437A (es)
WO (1) WO1996031529A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
IL125262A0 (en) 1998-07-07 1999-03-12 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6935730B2 (en) 2000-04-03 2005-08-30 Unicorn Image Products Co. Ltd. Of Zhuhai One-way valve, valve unit assembly, and ink cartridge using the same
AU2003242886B2 (en) 2002-05-21 2008-04-10 Resistentia Pharmaceuticals Ab Chimeric IgE polypeptides and host cells
CN1169829C (zh) * 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection
KR20180004752A (ko) * 2015-05-26 2018-01-12 주식회사 젬백스앤카엘 신규 펩티드 및 이를 포함한 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Polypeptide des hepatitis c-virus (hiv)
JPH06511241A (ja) * 1991-09-23 1994-12-15 ジェネンテク，インコーポレイテッド 自己免疫疾患の診断および治療
EP0666867A4 (en) * 1992-09-14 1997-08-27 Brigham & Womens Hospital REAGENTS AND METHODS FOR TREATING RHUMATOID ARTHRITIS.

Also Published As

Publication number Publication date
ES2203685T3 (es) 2004-04-16
MX9707662A (es) 1997-11-29
CA2217679C (en) 2008-03-25
DE69629559D1 (de) 2003-09-25
DE69629559T2 (de) 2004-06-17
HUP9801680A2 (hu) 1998-11-30
EP0821003A1 (en) 1998-01-28
KR19980703610A (ko) 1998-12-05
AU704656B2 (en) 1999-04-29
NO974566D0 (no) 1997-10-02
EP0821003A4 (en) 2000-05-24
CN1183784A (zh) 1998-06-03
WO1996031529A1 (fr) 1996-10-10
CA2217679A1 (en) 1996-10-10
NZ304437A (en) 1999-01-28
JPH08333390A (ja) 1996-12-17
ATE247664T1 (de) 2003-09-15
EP0821003B1 (en) 2003-08-20
AU5162296A (en) 1996-10-23
HUP9801680A3 (en) 1999-06-28

Similar Documents

Publication Publication Date Title
Yang et al. Sugar-assisted ligation in glycoprotein synthesis
AU758843B2 (en) Compounds of unstable dipeptidyl peptidase IV inhibitors
DK0750506T3 (da) Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse
DE68916932D1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
AU4837300A (en) Antimicrobial theta defensins and methods of using same
Pote et al. Otoconin-22, the major protein of aragonitic frog otoconia, is a homolog of phospholipase A2
NO974566D0 (no) Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
TWI325430B (en) Aminated complex type sugar chain derivative and its production method
Karlsson Chemistry of some potent animal toxins
CA2453112A1 (en) New cationic peptides of the dermaseptin family isolated from the skin secretion of phyllomedusa hypochondrialls
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
EP0836617A1 (en) Parevins and tachytegrins
US6307016B1 (en) Parevins and tachytegrins
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
US20180072775A1 (en) Beta-Hairpin Peptidomimetics
TW202221010A (zh) 抑菌擬肽物
Gaudron et al. NAcSDKP analogues resistant to angiotensin-converting enzyme
Ding et al. Solid‐Phase Total Synthesis and Antimicrobial Activities of Loloatins A–D
US5962407A (en) Loloatin derivatives and analogs
WO1998004584A1 (en) Cyclic decapeptide antibiotics
US6790829B1 (en) Cyclic decapeptide antibiotics
WO2006108686A3 (en) Bnp agonists

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application